Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Versatile topical DNA vaccine undergoes preliminary clinical study in HIV

Jan. 9, 2006

Novel HIV integrase inhibitors designed by Bioflexis

Jan. 5, 2006

New agents with activity against HIV reported in patent literature

Jan. 4, 2006

Samaritan initiates new phase IIb for SP-01A in HIV

Jan. 4, 2006

Further development of Tanox's novel HIV drug TNX-355 supported by recent data

Dec. 30, 2005

New HIV integrase inhibitors claimed in recent Bristol-Myers Squibb patent

Dec. 30, 2005

NDA submitted for protease inhibitor TMC-114

Dec. 29, 2005

Compounds demonstrating activity against HIV disclosed in recent patent literature

Dec. 22, 2005

New data on vicriviroc presented at ICAAC

Dec. 22, 2005

Compounds with potential in the treatment of HIV infection disclosed

Dec. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...